PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 282 of 640

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07760077: Phase I Study of QLS1510 Tablets in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07759869: A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07759427: Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07751159: Radiation Therapy Approaches for People With Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07696260: Evaluation of Alexithymia and Its Relationship With Clinical Parameters in Patients With Chronic Coccydynia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07583563: An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07475806: A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07420907: Study of the Progression of Chronic Cardiovascular Conditions

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07414979: Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07297667: GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07256249: Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07247279: Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07227909: NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07226817: A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07111637: Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06995703: Increasing Screening for Cancer Using EHR-Nudges Replication

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06908057: Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06619236: Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06349083: Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06234397: Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06192160: Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06161519: PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05914155: Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05847894: Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05489887: Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05417594: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05240170: RIRS for Treatment of Stones in Congenital Anomalous Kidneys

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05211401: Rituximab in Patients With ST-elevation Myocardial Infarction

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05102799: MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05071612: Parallel Arm Trial of AD109 and AD504 In Patients With OSA

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04965454: Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04951453: Systemic Nitrosative/Oxidative Stress in Patients With Acute Brain Injury

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04394546: CHAMPION-AF Clinical Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03986034: Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03809351: UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03584802: Therapeutic Plasma Exchange, Rituximab and IV Ig for Severe Acute Exacerbation of IPF Admitted in ICU

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02688894: The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01473628: Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🌍Researchanswers.childrenshospital.orgTier 2 · Direct publisher

How ‘good’ bacteria from fecal transplants reduce peanut allergy

Boston Children's HospitalOriginal source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Regarding a Report Concerning Sumitomo Pharma (The Company's Views on “Sumitomo Chemical and Sumitomo Pharmaceutical: Part II - CiRA, Dr. Yamanaka, and the undisclosed history of image duplication concerns”)

Sumitomo PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (TSE:4502) Wins ORZEYFUL Approval, Where Does Fair Value Sit?

Yahoo FinanceOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

100th patient enrolled in PARTNERS trial to identify the first effective treatments for Bundibugyo ebolavirus disease

Oxford MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Congress could undermine NC’s biotech boom

carolinajournal.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PDS Biotech Prioritizes PDS0301 After 71% Response Rate In Colorectal Cancer And Discontinues PDS0101 Phase 3 Trial

Pulse 2.0Original source
🇺🇸Researchnews.nm.orgTier 2 · Direct publisher

Northwestern Medicine Huntley Hospital Celebrates 10 Years, Welcomes First Patient Family Back

Northwestern MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LEGN) 2026-08-11

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This trail-blazing Chilean lab is bringing biotech to the masses

World Bio Market InsightsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stakeholders call for flexibility in guidance aimed at reducing animal testing for cancer drugs

RAPSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA lays out plan to close ingredients, food-contact substances ‘loophole’

Packaging DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

The Manila TimesOriginal source
🇧🇷Regulatoryinterfarma.org.brTier 1 · Regulatory source

Interfarma na imprensa: Jornal Hoje destaca atraso no acesso a medicamentos já incorporados ao SUS

Interfarma BrazilOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Respiratory syncytial virus (RSV) programme: information for healthcare professionals

This guidance is for health practitioners implementing the vaccination programme to protect pregnant...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Guggenheim cuts Tenax Therapeutics price target to $4 on trial miss

Investing.com UKOriginal source
🇺🇸Industryir.codexis.comTier 1 · Company source

Codexis Reports Second Quarter 2026 Financial Results

CodexisOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Orleans-based biotech startup lands $1.25M grant for cancer test

neworleanscitybusiness.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Executive Order Reduces Childhood Vaccine Recommendations | PharmExec

pharmexec.comOriginal source
🇺🇸Industryneogenomics.comTier 1 · Company source

PanTracer™ Portfolio

NeoGenomicsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SynaptixBio: Rare Disease Biotech Investment Rising in US After PRV Renewal, UK Lagging Behind

BioPharm InternationalOriginal source